OSTEOGENESIS IMPERFECTA (OI)
Clinical trials for OSTEOGENESIS IMPERFECTA (OI) explained in plain language.
Never miss a new study
Get alerted when new OSTEOGENESIS IMPERFECTA (OI) trials appear
Sign up with your email to follow new studies for OSTEOGENESIS IMPERFECTA (OI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug hopes to fortify fragile bones in brittle bone disease trial
Disease control Recruiting nowThis study tests an experimental drug called AGA2115 in 80 adults with osteogenesis imperfecta (brittle bone disease) types I, III, or IV. The goal is to see if it safely increases bone density compared to a placebo over 12 months. Participants must have a confirmed genetic diagn…
Matched conditions: OSTEOGENESIS IMPERFECTA (OI)
Phase: PHASE2 • Sponsor: Angitia Incorporated Limited • Aim: Disease control
Last updated May 26, 2026 05:25 UTC
-
Brittle bone disease may impact heart health – new study investigates
Knowledge-focused Recruiting nowThis study looks at heart structure and function in people with osteogenesis imperfecta (OI), a condition that makes bones fragile. Researchers want to learn how often heart problems occur in people with OI. About 40 participants will have heart tests. No treatment is given; the …
Matched conditions: OSTEOGENESIS IMPERFECTA (OI)
Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC